You want to pay attention to everybody, but who are the ones that you really want to pay attention to? And I think what the study’s telling you, older women, women who are obese—you need to really pay attention to.
I think that it probably represents a failure in our health care system. It just points out an opportunity, from a quality improvement standpoint, to make sure that everybody who is going to have a hysterectomy has the appropriate assessment for the risk of cancer preoperatively.
The data available to US Preventive Services Task Force didn't address an important question: what do you recommend to African American men who are twice as likely to develop prostate cancer and die from it as the general population?
Bristol-Myers Squibb's three-year collaboration with Flatiron Health will focus on leveraging real-world data to improve the pharmaceutical company's regulatory submissions, demonstrate the economic value of BMS's cancer portfolio, and to study the predictive value of biomarkers.
Recently, Peter Tunney, an artist who runs two galleries in the Wynwood Walls Park in Miami, provided artwork to wrap an RV that Sylvester Comprehensive Cancer Center will use to take cancer interventions to Little Haiti, Liberty City, Little Havana and LGBTQ neighborhoods.
Richard and Susan Rogel gave $150 million to the University of Michigan Comprehensive Cancer Center, which will now be known as the Rogel Cancer Center.
Patients and their doctors should be able to make treatment decisions without involvement from the federal government, said Starlee Coleman, senior policy advisor for the Goldwater Institute, a libertarian think tank that lobbied successfully for widespread adoption of right-to-try laws.
The right-to-try bills passed by Congress would remove FDA's expanded access mandate and leave patients at greater risk, said Arthur Caplan, the Drs. William F. and Virginia Connolly Mitty Professor and founding director of the Division of Medical Ethics at the New York University School of Medicine.